Global Gastroesophageal Reflux Disease (GERD) Market Trends 2025–2029: Regional Outlook and Sizing Analysis
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Gastroesophageal Reflux Disease (GERD) Market In The Coming Years?
The market scale of gastroesophageal reflux disease (gerd) has witnessed a slight increase in the past years, projecting a growth from $5.25 billion in 2024 to $5.33 billion in 2025, with a compound annual growth rate (CAGR) of 1.6%. The reasons behind such growth during the historical period include changes in lifestyle and diet, the increasing prevalence of obesity, enhanced awareness regarding gerd therapy, the global expansion of the pharmaceutical industry, and investments directed towards gerd treatments.
The market size of gastroesophageal reflux disease (gerd) is projected to experience consistent growth in the forthcoming years, with a valuation of $5.95 billion by 2029, thanks to a compound annual growth rate (CAGR) of 2.8%. Factors expected to contribute to this growth within the forecast period include an aging population, elevated healthcare expenditures, the emergence of biomarkers, increased gerd screening programs, a rise in heartburn prevalence, and a heightened demand for medical supplies. The forecast period will also be marked by significant trends such as advancements in diagnostics and surgery, the creation of targeted treatments, and the uptake of telehealth services.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12917&type=smp
Which Growth Drivers Are Shaping The Gastroesophageal Reflux Disease (GERD) Market Outlook?
The increasing occurrence of diseases related to the esophagus is anticipated to spur the expansion of the gastroesophageal reflux disease (GERD) market in the future. Medical conditions that impact the esophagus, the muscular conduit connecting the mouth and stomach, are classified as esophageal diseases. The goal of treating these diseases is to ease symptoms, enhance the quality of life, and prevent complications, thereby fostering improved general health and well-being for individuals affected by gastroesophageal reflux disease. For example, the American Cancer Society, a professional organization based in the US, reported in January 2023 that about 21,560 new cases of esophageal cancer are diagnosed in the United States each year, leading to 16,120 deaths. Thus, the rising prevalence of esophageal diseases propels the gastroesophageal reflux disease (GERD) market’s development.
What Is The Segment Breakdown Of The Gastroesophageal Reflux Disease (GERD) Market?
The gastroesophageal reflux disease (gerd)market covered in this report is segmented –
1) By Drug Type: Antacids; Proton Pump Inhibitors; H2 Receptor Blocker; Pro Kinetic Agents; Dopamine Receptor Antagonist; EndoCinch; Stretta; EsophyX; Transoral Incisionless Fundoplication (TIF)
2) By Procedure: Invasive; Minimally Invasive
3) By End-Users: Hospital; Homecare; Specialty Clinics
Subsegments:
1) By Antacids: Calcium Carbonate; Magnesium Hydroxide; Aluminum Hydroxide
2) By Proton Pump Inhibitors: Omeprazole; Esomeprazole; Lansoprazole; Pantoprazole; Rabeprazole
3) By H2 Receptor Blockers: Ranitidine; Famotidine; Nizatidine; Cimetidine
4) By Prokinetic Agents: Metoclopramide; Domperidone
5) By Dopamine Receptor Antagonists: Prochlorperazine; Droperidol
6) By EndoCinch: Endoscopic Suturing Systems
7) By Stretta: Radiofrequency Ablation Systems
8) By EsophyX: Transoral Fundoplication Systems
9) By Transoral Incisionless Fundoplication (TIF): TIF Devices And Systems
What Are The Dominant Trends Currently Seen In The Gastroesophageal Reflux Disease (GERD) Market?
Key players in the gastroesophageal reflux disease (GERD) market are concentrating their efforts on developing cutting-edge GERD treatment devices to maintain their standings. For example, in April 2023, the American company Laborie Medical Technologies unveiled the alpHaONE wireless pH-capsule reflux testing diagnostic system, specifically engineered for the detection of gastroesophageal reflux disease. This advanced system is capable of collecting monitoring data for up to 96 hours and is suitably compact, boasting large buttons and a dependable capsule delivery mechanism. The system is also equipped with a software application that includes a virtual instruction program and the ability to personalize symptom buttons, thereby enhancing the user experience.
Who Are The Major Stakeholders Operating In The Gastroesophageal Reflux Disease (GERD) Market?
Major companies operating in the gastroesophageal reflux disease (GERD) market are GlaxoSmithKline PLC, SRS Life Sciences, Johnson & Johnson Services Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Reckitt Benckiser Group PLC, Eisai Co. Ltd., Pfizer Inc., Medtronic PLC, Teva Pharmaceuticals, HK inno.N Corporation, Sebela Pharmaceuticals, Mylan N.V., Bausch Health Companies Inc., Johnson & Johnson MedTech, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc., Almirall S.A., HK inno.N Corporation, SRS Life Sciences Pte. Ltd.
Access The Complete Report Here:
Which Region Is Likely To Register The Fastest Growth In The Gastroesophageal Reflux Disease (GERD) Market?
North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastroesophageal reflux disease (GERD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12917&type=smp
Browse Through More Reports Similar to the Global Gastroesophageal Reflux Disease (GERD) Market 2025, By The Business Research Company
Inflammatory Bowel Disease Treatment Global Market Report 2025
Irritable Bowel Syndrome Ibs Treatment Global Market Report 2025
Gastric Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
